‘Affordable Medicines’: what has changed since 4 May
This has been reported by the National Health Service of Ukraine.
Seven international non-proprietary names (INNs) have been added to the list, including modern innovative medicines for the treatment of cardiovascular diseases, the prevention of strokes and thrombosis, type 2 diabetes and chronic respiratory diseases.
Among the new medicines are:
- ‘Xarelto’, ‘Pradaxa’, ‘Eliquis’ – for the prevention of thrombosis and strokes;
- ‘Forxiga’, ‘Jardins’ – for the treatment of type 2 diabetes;
- atorvastatin-based preparations and combination therapies for the treatment of COPD.
These medicines are part of modern pharmacotherapy, but were previously largely inaccessible to patients due to their high cost.
It is noted that a fixed reimbursement mechanism applies to new medicines:
- the state reimburses a specified portion of the cost;
- the patient pays the difference depending on the price at the pharmacy.
The National Health Service clarified that prescriptions are issued by GPs or relevant specialists without the need to draw up a separate treatment plan.
An electronic prescription is generated in the ESOS system, after which the medicines can be obtained from pharmacies that have a contract with the National Health Service – currently there are over 17,000 such pharmacies.
As of the end of April 2026, the programme covers:
- 778 items, including:
- 650 medicinal products;
- 59 insulin preparations;
- 34 combination preparations;
- 36 medical devices;
- of which 284 are free of charge, and a further 494 are subject to a partial co-payment.
Follow us on Telegram
